These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2083 related items for PubMed ID: 8644861

  • 1. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
    Pötgens AJ, van Altena MC, Lubsen NH, Ruiter DJ, de Waal RM.
    Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
    [Abstract] [Full Text] [Related]

  • 2. Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.
    Pötgens AJ, Lubsen NH, van Altena MC, Schoenmakers JG, Ruiter DJ, de Waal RM.
    Am J Pathol; 1995 Jan; 146(1):197-209. PubMed ID: 7531947
    [Abstract] [Full Text] [Related]

  • 3. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, Dvorak HF.
    Cancer Res; 1996 Jan 01; 56(1):172-81. PubMed ID: 8548760
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F, Robles AI, Duran H, Murillas R, Quintanilla M, Cano A, Conti CJ, Jorcano JL.
    Cancer Res; 1996 Dec 01; 56(23):5391-6. PubMed ID: 8968091
    [Abstract] [Full Text] [Related]

  • 5. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 01; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production.
    Zeng G, Gao L, Birklé S, Yu RK.
    Cancer Res; 2000 Dec 01; 60(23):6670-6. PubMed ID: 11118051
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 Nov 01; 81(5):774-82. PubMed ID: 10555745
    [Abstract] [Full Text] [Related]

  • 10. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.
    Kondo S, Asano M, Suzuki H.
    Biochem Biophys Res Commun; 1993 Aug 16; 194(3):1234-41. PubMed ID: 7688963
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene.
    Belletti B, Ferraro P, Arra C, Baldassarre G, Bruni P, Staibano S, De Rosa G, Salvatore G, Fusco A, Persico MG, Viglietto G.
    Oncogene; 1999 Aug 26; 18(34):4860-9. PubMed ID: 10490819
    [Abstract] [Full Text] [Related]

  • 13. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
    Abu-Jawdeh GM, Faix JD, Niloff J, Tognazzi K, Manseau E, Dvorak HF, Brown LF.
    Lab Invest; 1996 Jun 26; 74(6):1105-15. PubMed ID: 8667614
    [Abstract] [Full Text] [Related]

  • 14. Tumor-secreted vascular permeability factor/vascular endothelial growth factor influences photosensitizer uptake.
    Roberts WG, Hasan T.
    Cancer Res; 1993 Jan 01; 53(1):153-7. PubMed ID: 8416739
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.
    Asano M, Yukita A, Matsumoto T, Kondo S, Suzuki H.
    Cancer Res; 1995 Nov 15; 55(22):5296-301. PubMed ID: 7585591
    [Abstract] [Full Text] [Related]

  • 16. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts.
    Yu JL, Rak JW, Klement G, Kerbel RS.
    Cancer Res; 2002 Mar 15; 62(6):1838-46. PubMed ID: 11912163
    [Abstract] [Full Text] [Related]

  • 17. Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
    Graff BA, Bjørnaes I, Rofstad EK.
    Microvasc Res; 2001 Mar 15; 61(2):187-98. PubMed ID: 11254398
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK, Halsør EF.
    Cancer Res; 2000 Sep 01; 60(17):4932-8. PubMed ID: 10987309
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 20. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis.
    Rofstad EK, Danielsen T.
    Br J Cancer; 1999 Aug 15; 80(11):1697-707. PubMed ID: 10468285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 105.